Trademark applications and grants for Plexxikon Inc. Plexxikon Inc has 8 trademark applications. The latest application filed is for "PLEXXIKON ENGINEERING DRUGS FOR PERSONALIZED MEDICINE"
Patent Application | Date |
---|---|
FORMULATIONS OF A COMPOUND MODULATING KINASES 20220184079 - 17/684954 Rezaei; Hamid ;   et al. | 2022-06-16 |
SOLID FORMS OF A COMPOUND MODULATING KINASES 20220153737 - 17/535304 Ibrahim; Prabha N. ;   et al. | 2022-05-19 |
COMPOUNDS AND METHODS FOR CD73 MODULATION AND INDICATIONS THEREFOR 20220144805 - 17/238121 Shi; Songyuan ;   et al. | 2022-05-12 |
SOLID FORMS OF A COMPOUND FOR MODULATING KINASES 20220081436 - 17/368582 Ibrahim; Prabha N. ;   et al. | 2022-03-17 |
COMBINATIONAL DRUG THERAPIES 20220054507 - 17/407811 Powell; Ben ;   et al. | 2022-02-24 |
NCAGE Code | 61QH7 | PLEXXIKON INC. |
CAGE Code | 61QH7 | PLEXXIKON INC. |
DUNS | 025287462 | PLEXXIKON INC. |
SEC | 0001142588 | PLEXXIKON INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.